Advancedneuro Corp | |
13010 Arbor Isle Dr Unit 102 Temple Terr FL 33637-1145 | |
(201) 590-5104 | |
(813) 315-6299 |
Full Name | Advancedneuro Corp |
---|---|
Speciality | Psychiatry & Neurology |
Location | 13010 Arbor Isle Dr Unit 102, Temple Terr, Florida |
Authorized Official Name and Position | Chirag Savani (MD) |
Authorized Official Contact | 2015905104 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Advancedneuro Corp 13010 Arbor Isle Dr Unit 102 Temple Terr FL 33637-1145 Ph: (201) 590-5104 | Advancedneuro Corp 13010 Arbor Isle Dr Unit 102 Temple Terr FL 33637-1145 Ph: (201) 590-5104 |
NPI Number | 1043893878 |
---|---|
Provider Enumeration Date | 04/29/2021 |
Last Update Date | 04/29/2021 |
Certification Date | 04/29/2021 |
Medicare PECOS PAC ID | 3476962168 |
---|---|
Medicare Enrollment ID | O20210510002008 |
News Archive
Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that stimulating expression of a protein naturally produced by the human body can be a strategy to combat loss of skeletal muscle mass, which happens normally with aging but can intensify in cases of neurodegenerative or inflammatory disease, or in patients who spend long periods in intensive care units (ICUs).
The results of an innovative study to understand what factors may influence who contracts tuberculosis (TB)/HIV co-infection in San Diego show a significant shift in the ethnic makeup of the disease, with the majority of cases now coming from the Hispanic community.
Northwestern Medicine scientists showed for the first time that non-invasive brain stimulation can be used like a scalpel, rather than like a hammer, to cause a specific improvement in precise memory.
In this post in the Huffington Post Blog, Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, examines a nationwide vaccination campaign in Haiti, through which "health officials are targeting measles, rubella and polio and [are] also introducing pentavalent vaccine, one shot against five diseases."
Alexza Pharmaceuticals, Inc. announced today that the British Journal of Psychiatry, a publication of the Royal College of Psychiatrists, has published the results of the pivotal Phase 3 study evaluating AZ-004 (inhaled or Staccato® loxapine) for the rapid treatment of agitation in patients with schizophrenia, in its January 2011 edition (198:51-58).
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1043893878 | NPI | - | NPPES |
ME146254 | Other | FL | STATE LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | (* (Not Available)) | Primary |
Provider Name | Chirag Savani |
---|---|
Provider Type | Practitioner - Neurology |
Provider Identifiers | NPI Number: 1194263178 PECOS PAC ID: 3870843717 Enrollment ID: I20210510002110 |
News Archive
Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that stimulating expression of a protein naturally produced by the human body can be a strategy to combat loss of skeletal muscle mass, which happens normally with aging but can intensify in cases of neurodegenerative or inflammatory disease, or in patients who spend long periods in intensive care units (ICUs).
The results of an innovative study to understand what factors may influence who contracts tuberculosis (TB)/HIV co-infection in San Diego show a significant shift in the ethnic makeup of the disease, with the majority of cases now coming from the Hispanic community.
Northwestern Medicine scientists showed for the first time that non-invasive brain stimulation can be used like a scalpel, rather than like a hammer, to cause a specific improvement in precise memory.
In this post in the Huffington Post Blog, Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, examines a nationwide vaccination campaign in Haiti, through which "health officials are targeting measles, rubella and polio and [are] also introducing pentavalent vaccine, one shot against five diseases."
Alexza Pharmaceuticals, Inc. announced today that the British Journal of Psychiatry, a publication of the Royal College of Psychiatrists, has published the results of the pivotal Phase 3 study evaluating AZ-004 (inhaled or Staccato® loxapine) for the rapid treatment of agitation in patients with schizophrenia, in its January 2011 edition (198:51-58).
› Verified 9 days ago
Provider Name | Elisa Martinez Garcia |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1932871076 PECOS PAC ID: 6204225345 Enrollment ID: I20211111001749 |
News Archive
Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that stimulating expression of a protein naturally produced by the human body can be a strategy to combat loss of skeletal muscle mass, which happens normally with aging but can intensify in cases of neurodegenerative or inflammatory disease, or in patients who spend long periods in intensive care units (ICUs).
The results of an innovative study to understand what factors may influence who contracts tuberculosis (TB)/HIV co-infection in San Diego show a significant shift in the ethnic makeup of the disease, with the majority of cases now coming from the Hispanic community.
Northwestern Medicine scientists showed for the first time that non-invasive brain stimulation can be used like a scalpel, rather than like a hammer, to cause a specific improvement in precise memory.
In this post in the Huffington Post Blog, Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, examines a nationwide vaccination campaign in Haiti, through which "health officials are targeting measles, rubella and polio and [are] also introducing pentavalent vaccine, one shot against five diseases."
Alexza Pharmaceuticals, Inc. announced today that the British Journal of Psychiatry, a publication of the Royal College of Psychiatrists, has published the results of the pivotal Phase 3 study evaluating AZ-004 (inhaled or Staccato® loxapine) for the rapid treatment of agitation in patients with schizophrenia, in its January 2011 edition (198:51-58).
› Verified 9 days ago
News Archive
Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that stimulating expression of a protein naturally produced by the human body can be a strategy to combat loss of skeletal muscle mass, which happens normally with aging but can intensify in cases of neurodegenerative or inflammatory disease, or in patients who spend long periods in intensive care units (ICUs).
The results of an innovative study to understand what factors may influence who contracts tuberculosis (TB)/HIV co-infection in San Diego show a significant shift in the ethnic makeup of the disease, with the majority of cases now coming from the Hispanic community.
Northwestern Medicine scientists showed for the first time that non-invasive brain stimulation can be used like a scalpel, rather than like a hammer, to cause a specific improvement in precise memory.
In this post in the Huffington Post Blog, Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, examines a nationwide vaccination campaign in Haiti, through which "health officials are targeting measles, rubella and polio and [are] also introducing pentavalent vaccine, one shot against five diseases."
Alexza Pharmaceuticals, Inc. announced today that the British Journal of Psychiatry, a publication of the Royal College of Psychiatrists, has published the results of the pivotal Phase 3 study evaluating AZ-004 (inhaled or Staccato® loxapine) for the rapid treatment of agitation in patients with schizophrenia, in its January 2011 edition (198:51-58).
› Verified 9 days ago
Anthony Dwight Bobo, Sr Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7501 Okeechobee Ct, Temple Terr, FL 33637 Phone: 330-573-4722 |